NCT06302777 (MAIN-IMAGE) is a clinical trial in Coronary Artery Disease, sponsored by Goethe University.

Who is sponsoring NCT06302777?

NCT06302777 is sponsored by Goethe University.

What condition does NCT06302777 study?

NCT06302777 studies Coronary Artery Disease.

Is NCT06302777 still recruiting?

NCT06302777 is currently recruiting now. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT06302777: MAIN-IMAGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MAIN-IMAGE Registry

Recruiting now Last updated 12 March 2024

What this trial tests

trial in Coronary Artery Disease in 500 participants. Currently enrolling.

Timeline

26 September 2023

Primary endpoint
26 September 2028

26 September 2031

Quick facts

Lead sponsor	Goethe University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	26 September 2023
Primary completion	26 September 2028
Estimated completion	26 September 2031
Sites	2 locations across Germany

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Goethe University

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All comers registry with patients with chronic coronary syndrome or acute coronary syndrome who underwent intracoronary imaging during cardiac catherization. The aim is to identify plaque characteristics on OCT or IVUS that are associated with adverse cardiac events including myocardial infarction and atherosclerotic progression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Goethe University trials

Trials by the same sponsor.

NCT07422844 — Dynamic Network Response to TMS Treatment · recruiting
NCT07008261 — Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. · recruiting
NCT06879184 — Cohort of the Specialist Network Infectious Diseases · not yet recruiting
NCT06201936 — EPIDURAL- Evaluation of Preexisting Information Regarding Neuroaxial Procedures for Labour Analgesia · recruiting
NCT06627140 — Expected and Actual Preterm-Birth and Parental Distress: Impact on Children's Mental Health · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06302777 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Goethe University
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06302777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing